Dalton supplies chemistry, analytical and formulation development services to the biotechnology and pharmaceutical industries in the areas of chemistry, medicinal chemistry and fine chemical manufacture.
The company provides cGMP manufacturing of solid dosage forms and aseptic filling services to its customers at any stage of the regulatory process (Phase I, II, III or commercial).
Dalton Pharma president and CEO Peter Pekos said that their clients have been asking for this full spectrum of capabilities to fill an important need in the industry.
"In Lonza we have the ideal partner: experienced process R&D- and scale-up experts with early clinical trial to large scale commercial cGMP and ISO manufacturing at their sites in Switzerland and China," Pekos said.
Lonza Chemical Custom Manufacturing head Stefan Stoffel said that they are very pleased to have established and qualified Dalton Pharma Services as Lonza-trusted partner.
"Their services complement Lonza’s existing small molecules capabilities and add the desired proximity to key customers in the North American pharmaceutical market," Stoffel said.
Lonza has capabilities in large and small molecules, peptides, amino acids and niche bioproducts, which play an important role in the development of novel medicines and healthcare products.